Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases: Insights From Pulmonary Arterial Hypertension

BACKGROUND: Conducting randomized controlled trials to investigate survival in a rare disease like pulmonary arterial hypertension has considerable ethical and logistical constraints. In many studies, such as the Study with an Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Torbicki, Adam, Bacchi, Marisa, Delcroix, Marion, Farber, Harrison W., Ghofrani, Hossein-Ardeschir, Hennessy, Brian, Jansa, Pavel, Mehta, Sanjay, Perchenet, Loïc, Pulido, Tomas, Rosenberg, Daniel, Rubin, Lewis J., Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Wei, Lee-Jen, Channick, Richard, Benza, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665498/
https://www.ncbi.nlm.nih.gov/pubmed/31109190
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665498/
https://www.ncbi.nlm.nih.gov/pubmed/31109190
http://dx.doi.org/10.1161/CIRCOUTCOMES.118.005095

Ejemplares similares